REV3L confers chemoresistance to cisplatin in human gliomas: The potential of its RNAi for synergistic therapy-Reference-Cited by-同舟云学术

REV3L confers chemoresistance to cisplatin in human gliomas: The potential of its RNAi for synergistic therapy

Published:2009-12-01 Issue:6 Volume:11 Page:790-802
ISSN:1523-5866
Container-title:Neuro-Oncology
language:en
Short-container-title:

Author:

Wang Huibo,Zhang Shu-Yu,Wang Shuai,Lu Juan,Wu Wenting,Weng Lin,Chen Dan,Zhang Yu,Lu Zhipeng,Yang Jingmin,Chen Yuanyuan,Zhang Xu,Chen Xiaofeng,Xi Caihua,Lu Daru,Zhao Shiguang

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Neurology (clinical),Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/11/6/790/13065746/09_NO08-00174_Zhao_FF.pdf

Reference46 articles.

1. Behin A, Hoang-Xuan K, Carpentier AF, Delattre JY. Primary brain tumours in adults. Lancet. 2003;361:323-331.

2. Furnari FB, Fenton T, Bachoo RM, et al. Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev. 2007;21:2683-2710.

3. Barzon L, Zanusso M, Colombo F, Palu G. Clinical trials of gene therapy, virotherapy, and immunotherapy for malignant gliomas. Cancer Gene Ther. 2006;13:539-554.

4. DeAngelis LM. Brain tumors. N Engl J Med. 2001;344:114-123.

5. Okada H, Pollack IF. Cytokine gene therapy for malignant glioma. Expert Opin Biol Ther. 2004;4:1609-1620.

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protein Assemblies in Translesion Synthesis;Genes;2024-06-24

2. Enzymatic Processing of DNA–Protein Crosslinks;Genes;2024-01-10

3. Cisplatin in cancer treatment;Biochemical Pharmacology;2022-12

4. Leveraging the replication stress response to optimize cancer therapy;Nature Reviews Cancer;2022-11-02

5. Glioma stem cell signature predicts the prognosis and the response to tumor treating fields treatment;CNS Neuroscience & Therapeutics;2022-09-07